ARTICLES & ANALYSIS
Evidence, explained.
Clear, careful reporting on psychedelic medicine—what research can tell us, what it cannot, and why the distinction matters.
Plain-English reporting
Evidence in context
Safety-aware language
Sources you can inspect
LATEST PUBLISHED WORK
Start with the evidence
-
FOUNDATIONAL GUIDE
How to Spot Misleading Psychedelic Clinic and Retreat Claims
Read article →: How to Spot Misleading Psychedelic Clinic and Retreat ClaimsA practical checklist for testing treatment promises, credentials, regulation, testimonials and safety claims before money or trust changes hands.
-
FOUNDATIONAL GUIDE
Can Psychedelic Trials Really Be Blinded?
Read article →: Can Psychedelic Trials Really Be Blinded?How obvious drug effects create functional unblinding, why it can bias outcomes, and what better psychedelic trials do to limit the damage.
-
FOUNDATIONAL GUIDE
Psychedelics and Depression: Comparing the Different Research Approaches
Read article →: Psychedelics and Depression: Comparing the Different Research ApproachesWhy psilocybin depression trials can reach different answers—and how population, control, support and follow-up shape every result.
-
FOUNDATIONAL GUIDE
Therapists, Boundaries and Safeguarding in Psychedelic Research
Read article →: Therapists, Boundaries and Safeguarding in Psychedelic ResearchWhy altered states heighten safeguarding duties, what responsible research systems include, and which warning signs deserve scrutiny.
-
FOUNDATIONAL GUIDE
What Does “Psychedelic-Assisted Therapy” Really Mean?
Read article →: What Does “Psychedelic-Assisted Therapy” Really Mean?A plain-English guide to preparation, drug sessions, psychological support and integration—and why protocols cannot be treated as interchangeable.
-
FOUNDATIONAL GUIDE
Microdosing Psychedelics: What Does the Evidence Actually Show?
Read article →: Microdosing Psychedelics: What Does the Evidence Actually Show?Controlled microdosing studies, placebo effects and the limits of current evidence—explained without hype or dosing advice.
-
FOUNDATIONAL GUIDE
Psychedelic Medicine and UK Law: Research, Scheduling and Access
Read article →: Psychedelic Medicine and UK Law: Research, Scheduling and AccessA plain-English guide to UK drug classes, schedules, research licences and why a clinical trial does not create routine medical or legal access.
-
FOUNDATIONAL GUIDE
Screening, Contraindications and Risk in Psychedelic Research
Read article →: Screening, Contraindications and Risk in Psychedelic ResearchWhy clinical screening reduces but cannot eliminate risk, what trials monitor, and why selected research populations should not be generalised.
-
FOUNDATIONAL GUIDE
Ketamine and Classic Psychedelics Are Not the Same
Read article →: Ketamine and Classic Psychedelics Are Not the SameHow ketamine differs from psilocybin and LSD in pharmacology, clinical use, evidence, legal status and risk—despite sharing the psychedelic conversation.
-
FOUNDATIONAL GUIDE
MDMA-Assisted Therapy for PTSD: Evidence, Limits and Approval Status
Read article →: MDMA-Assisted Therapy for PTSD: Evidence, Limits and Approval StatusWhat phase 3 PTSD trials reported, why the FDA did not approve the application, and what safety, blinding and delivery questions remain.
WHAT YOU’LL FIND HERE
Three lenses on a complex field
01
Research & evidence
Study design, clinical findings, uncertainty and the distance between promising research and established care.
02
Regulation & ethics
How law, clinical governance, consent, access and commercial pressure shape the real-world conversation.
03
Mental health context
Potential benefits, known risks, clinical boundaries and the experiences too often flattened into headlines.
A PRACTICAL READING HABIT
Four questions before you share a claim
What is the claim?
Separate what the study measured from what a headline implies.
Who took part?
Small or selective groups may not represent wider populations.
What are the limits?
Look for uncertainty, follow-up length and alternative explanations.
Can I inspect it?
Prefer reporting that links to the underlying source or guidance.
Keep exploring
Use the Resources library to inspect primary sources, or read the Mission to understand how this publication approaches evidence.
Psychedelic Medicine Report 